Professor Hisham Mehanna

InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham

Professor Mehanna is the Chair of Head and Neck Surgery, and Director of InHANSE, at the University of Birmingham.

Hisham’s clinical interests are recurrence head and neck cancer surgery and thyroid and minimal access parathyroid surgery.

Hisham has a keen interest in clinical and translational research, heading a research team of 20 researchers, and holding over £10million in research grants. The main areas of his research are Human Papillomavirus-associated head and neck cancer and thyroid cancer. His research themes are drug development and redeployment, biomarkers of treatment response and early and late phase clinical trials in head and neck cancer. He is chief investigator of several multicentre and multinational clinical trials, including the PET NECK trial, published in the NEJM in 2016.

He is currently President of the British Association of Head Neck Oncologists (BAHNO) and past Chair of the Research Committee of BAHNO, the UK’s multi-disciplinary professional body, and past Chair of the UK’s National Cancer Research Institute’s head and neck group, responsible for all head neck cancer research in the UK.

dont miss

Clinical trials that change patient care and the lessons learnt

We will give examples of studies in head and neck cancer that have changed patient care, and the lessons learnt in running these studies.

Professor Hisham Mehanna will be speaking in the following theatre:

Theatre 11 - Wednesday 14.45 - 15.15: Clinical trials that change patient care and the lessons learnt

EVEN MORE SEMINARS

  • Stuart Dollow: Speaking at the Oncology Convention

    Stuart Dollow
    Vermilion Life Sciences Ltd

    Reengineering Medicines Development

  • Jocelyn Harding CEB DipDH: Speaking at the Oncology Convention

    Jocelyn Harding CEB DipDH
    Oralieve UK

    The importance of mouth care for cancer patients

  • Dr Sileida Oliveros: Speaking at the Oncology Convention

    Dr Sileida Oliveros
    GenesisCare

    Surface-Guided Radiotherapy and Optimal Breast Cancer Treatment

  • Dr. Richard Baird: Speaking at the Oncology Convention

    Dr. Richard Baird
    Cancer Research UK Cambridge Centre

    Update on Precision Medicine Approaches to Treat Metastatic Breast Cancer

  • Dr. Matthew Prime: Speaking at the Oncology Convention

    Dr. Matthew Prime
    Roche Diagnostics Information Solutions

    Personalized healthcare: Leveraging data to improve patient care through clinical decision support in oncology